Dexrazoxane Intravenous and Insulin degludec and liraglutide Subcutaneous
Determining the interaction of Dexrazoxane Intravenous and Insulin degludec and liraglutide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexrazoxane
Brand name: Totect, Zinecard
Synonyms: Dexrazoxane
Generic Name: insulin degludec / liraglutide
Brand name: Xultophy
Synonyms: Insulin degludec and liraglutide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dexrazoxane Intravenous-Insulin degludec Subcutaneous
- Dexrazoxane Intravenous-Insulin detemir
- Dexrazoxane Intravenous-Insulin Detemir (Cartridges and Prefilled Syringes)
- Dexrazoxane Intravenous-Insulin Detemir (Vials)
- Dexrazoxane Intravenous-Insulin detemir Subcutaneous
- Dexrazoxane Intravenous-Insulin glargine
- Insulin degludec and liraglutide Subcutaneous-Dextenza Insert
- Insulin degludec and liraglutide Subcutaneous-Dextenza intraocular
- Insulin degludec and liraglutide Subcutaneous-Dextran 40
- Insulin degludec and liraglutide Subcutaneous-Dextran 70 6% in 5% Dextrose high molecular weight
- Insulin degludec and liraglutide Subcutaneous-Dextran 75
- Insulin degludec and liraglutide Subcutaneous-Dextran high molecular weight